Skip to main content
Caplight Logo









MedaCube

MedaCube

Private
Rochester, New YorkHealthcare & Life Scienceshttps://www.medacube.com/

Last Round

Seed

Jan 1, 2026

Total Funding Raised

$2.75M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

MedaCube operates in Healthcare & Life Sciences and is based in Rochester, New York. Its latest recorded funding round was a Seed round in January 2026.

MedaCube is a medical device company that develops and provides an automatic pill dispenser designed to improve medication adherence.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Home & Lifestyle

Business Model

B2C

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

MedaCube Comparables

Compare MedaCube with similar companies based on industry and business-model similarity.

MedaCube comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PharmRight Corporation
88%
e-pill, LLC
88%
Hero Health
87%
Book a demo to see all comparables

For institutional investors. Book with your work email.

MedaCube Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 1, 2026
SeedOct 21, 2014
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Michel Berg

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

MedaCube Investors

Notable investors and investment history

MedaCube investors
InvestorRounds
Excell PartnersSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    $550K raised with Excell Partners

  • Jul 23, 2025

    Grew 33% QoQ from 9 to 12 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

MedaCube Filings

Explore SEC and related filing metadata, where available.

MedaCube filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about MedaCube's valuation, stock price, and market status.

Is MedaCube a public or private company?

MedaCube is a private company.

What is the current stock price of MedaCube?

MedaCube is a private company, so its shares have no public market price. Caplight tracks MedaCube's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is MedaCube worth (valuation)?

Valuation information for MedaCube is not publicly available.

Can I buy MedaCube stock?

MedaCube shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was MedaCube's last funding round?

MedaCube's most recent funding round was Seed on January 1, 2026.

Who are the main investors in MedaCube?

Key investors in MedaCube include Excell Partners.

Will MedaCube IPO soon?

No public IPO plans have been announced for MedaCube.

How can I track MedaCube secondary market activity?

Caplight tracks bids, offers, and trades in MedaCube's shares on secondary markets.

Firmographic Details

HeadquartersRochester, New York
Employee Range11
Year Founded2007
Last FundingJan 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?